NEXTBio Capital Management LP 13F holdings, Q2 2026
Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record
NEXTBio Capital Management LP disclosed 22 US equity positions worth $217.4m in its Q2 2026 13F filing. The largest position was PTGX at 12.4% of the reported book, followed by STTK and CMPS. Against the Q1 2026 filing, it opened 3 new positions, added to 7 and reduced 4 among the top 22 holdings.
What did NEXTBio Capital Management LP own in Q2 2026? Top 22 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2026 |
|---|---|---|---|---|---|---|---|
| 1 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 12.4% | $26.9m | 219,333 | -4% | reduced |
| 2 | STTK SHATTUCK LABS INC | Healthcare | 11.9% | $25.9m | 3,727,348 | 18% | added |
| 3 | CMPS COMPASS PATHWAYS PLC | Healthcare | 11.6% | $25.1m | 1,775,759 | -12% | reduced |
| 4 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 7.7% | $16.8m | 312,496 | 135% | added |
| 5 | VOR VOR BIOPHARMA INC | Healthcare | 7.5% | $16.4m | 889,164 | -11% | reduced |
| 6 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 6.7% | $14.6m | 131,758 | 5% | added |
| 7 | PVLA PALVELLA THERAPEUTICS INC NE | Healthcare | 6.3% | $13.7m | 89,909 | 9% | added |
| 8 | XENE XENON PHARMACEUTICALS INC | Healthcare | 5.1% | $11.1m | 183,225 | 0% | held |
| 9 | ZBIO ZENAS BIOPHARMA INC | 5.0% | $10.8m | 426,736 | 0% | held | |
| 10 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 3.5% | $7.6m | 706,124 | 35% | added |
| 11 | IVA INVENTIVA SA | 3.1% | $6.8m | 1,787,984 | 34% | added | |
| 12 | CBIO CRESCENT BIOPHARMA INC. | 3.1% | $6.7m | 372,856 | 0% | held | |
| 13 | PCVX VAXCYTE INC | Healthcare | 2.9% | $6.2m | 107,223 | 13% | added |
| 14 | COGT COGENT BIOSCIENCES INC | Healthcare | 2.3% | $5.1m | 131,075 | -0% | held |
| 15 | VSTM VERASTEM INC | Healthcare | 2.3% | $5.0m | 1,306,800 | 0% | held |
| 16 | IRON DISC MEDICINE INC | Healthcare | 1.8% | $3.9m | 52,655 | 0% | held |
| 17 | PHVS PHARVARIS N V | Healthcare | 1.7% | $3.7m | 108,055 | – | new |
| 18 | ZLAB ZAI LAB LTD | Healthcare | 1.6% | $3.5m | 183,362 | 0% | held |
| 19 | BIOA BIOAGE LABS INC | 1.1% | $2.5m | 100,732 | – | new | |
| 20 | LB PHARMACEUTICALS INC | 1.0% | $2.2m | 68,249 | – | new | |
| 21 | EVMN EVOMMUNE INC | 0.7% | $1.6m | 119,063 | -35% | reduced | |
| 22 | ACET ADICET BIO INC | 0.6% | $1.4m | 157,827 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.